PressMay 25, 2021 PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig’s Disease
PressMay 24, 2021 MindMed Announces Collaboration with Nextage Therapeutics’ Brain Targeting Liposome System
PressMay 21, 2021 The Chopra Foundation and MindMed to Partner on the Future of Psychedelic Medicines & Mental Wellbeing
PressMay 20, 2021 Awakn Life Sciences Inc. Enter into Binding Agreement for Reverse Takeover Transaction
PressMay 19, 2021 Silo Wellness Partners with Kaivalya Kollectiv to Include 5-MeO-DMT In Psychedelic Portfolio Offering
PressMay 19, 2021 MINDCURE Appoints Dr. John Brownstein, the Chief Innovation Officer at Boston Children’s Hospital, as Company Advisor
PressMay 18, 2021 HAVN Life to Acquire Clinical Stage IP for Development of LSD-Derived API for Cluster Headaches
PressMay 17, 2021 Revive Therapeutics Enters into Feasibility Agreement with LTS Lohmann to Develop Oral Psilocybin Thin Film Strip
PressMay 17, 2021 The World Boxing Council and Wesana Health Announce Joint Efforts to Research the Impact of Psychedelics on Traumatic Brain Injury
PressMay 6, 2021 Braxia Scientific Introduces “Braxia Health” a Growing Network of Clinics Leading Psychedelic Research
PressMay 4, 2021 Field Trip Health Ltd. Announces Opening of Psychedelic-Enhanced Therapy Center in Houston
